GHK-Cu

Copper Peptide

Copper complex of the tripeptide glycyl-L-histidyl-L-lysine, commonly included in topical cosmetic products and also sold by unregulated suppliers for injection. Much of the cited wound-repair evidence is laboratory or animal research; controlled systemic human evidence and injectable safety data are limited.

Pharmacokinetic model

A route-level PK model for ghk-cu is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Copper Peptide
Suggested cadence
once daily

Research behind this entry

  1. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds Maquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, Monboisse JC, Chastang F, Birembaut P, Gillery P · Journal of Clinical Investigation, 1993 DOI

    GHK-Cu injected into implanted rat wound chambers increased several extracellular-matrix measures in a concentration-dependent manner. This animal wound model does not establish cosmetic efficacy, systemic benefits,…

1 published study referenced in the app, each with a plain-language summary.